Generative AI Use Cases for Solving Pharmaceutical Bottlenecks
Generative AI Use Cases matter in biopharmaceutical development because the sector’s hardest constraints are connected. Target uncertainty produces weak candidates; weak candidates consume scarce preclinical capacity; complex protocols slow enrollment; fragmented evidence burdens regulatory authors; and fragile scale-up plans threaten launch supply. Applying a language model to one document may save hours without changing the development timeline. A stronger approach starts with a measurable bottleneck, examines its scientific and procedural causes, and combines generation with retrieval, prediction, workflow automation, and expert review. The landscape of Generative AI Use Cases is therefore best understood as a portfolio of problem-solving patterns rather than a catalog of model features. Some problems require hypothesis generation, others need evidence synthesis, and still others demand controlled document transformation. The appropriate architecture changes with the stakes. An exp...